标题
Precision oncology in the age of integrative genomics
作者
关键词
-
出版物
NATURE BIOTECHNOLOGY
Volume 36, Issue 1, Pages 46-60
出版商
Springer Nature
发表日期
2018-01-11
DOI
10.1038/nbt.4017
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Integrative clinical genomics of metastatic cancer
- (2017) Dan R. Robinson et al. NATURE
- Sharing Clinical and Genomic Data on Cancer — The Need for Global Solutions
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Chromosomal chaos silences immune surveillance
- (2017) Maurizio Zanetti SCIENCE
- Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
- (2017) Teresa Davoli et al. SCIENCE
- High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
- (2017) Christophe Massard et al. Cancer Discovery
- Liquid Biopsies for Cancer: Coming to a Patient near You
- (2017) Nithya Krishnamurthy et al. Journal of Clinical Medicine
- Gene Expression Analysis and Immunohistochemistry in Evaluation of Cancer of Unknown Primary: Time for a Patient-Centered Approach
- (2017) Charles R. Handorf Journal of the National Comprehensive Cancer Network
- Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium
- (2016) Laura M. Amendola et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Consideration of Cosegregation in the Pathogenicity Classification of Genomic Variants
- (2016) Gail P. Jarvik et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine
- (2016) Robert C. Green et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Epigenetic Therapeutics: A New Weapon in the War Against Cancer
- (2016) Nita Ahuja et al. Annual Review of Medicine
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Microsatellite Instability as a Biomarker for PD-1 Blockade
- (2016) J. C. Dudley et al. CLINICAL CANCER RESEARCH
- Germline Analysis from Tumor–Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings
- (2016) Bryce A. Seifert et al. CLINICAL CANCER RESEARCH
- Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants
- (2016) T. F. Beck et al. CLINICAL CHEMISTRY
- Incorporating genetic counseling into clinical care for children and adolescents with cancer
- (2016) Jessica N Everett et al. Future Oncology
- Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, andTERTpromoter hotspot mutations andTERTgene amplification as likely drivers of progression
- (2016) Salvatore Piscuoglio et al. JOURNAL OF PATHOLOGY
- Precision oncology: origins, optimism, and potential
- (2016) Vinay Prasad et al. LANCET ONCOLOGY
- Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience
- (2016) M. Schwaederle et al. MOLECULAR CANCER THERAPEUTICS
- Perspective: The precision-oncology illusion
- (2016) Vinay Prasad NATURE
- T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
- (2016) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The transformation of oncology
- (2016) H. Varmus SCIENCE
- Mutational signatures associated with tobacco smoking in human cancer
- (2016) L. B. Alexandrov et al. SCIENCE
- Mutational signatures of ionizing radiation in second malignancies
- (2016) Sam Behjati et al. Nature Communications
- Circulating tumor DNA detection in lung cancer patients before and after surgery
- (2016) Nannan Guo et al. Scientific Reports
- US president endorses “moonshot” effort to cure cancer
- (2016) Michael McCarthy BMJ-British Medical Journal
- Making sense of big data in health research: Towards an EU action plan
- (2016) Charles Auffray et al. Genome Medicine
- US president endorses “moonshot” effort to cure cancer
- (2016) Michael McCarthy BMJ-British Medical Journal
- Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors
- (2016) D. Williams Parsons et al. JAMA Oncology
- Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
- (2016) Howard I. Scher et al. JAMA Oncology
- Complete Durable Response From Carboplatin and Olaparib in a Heavily Pretreated Triple-Negative Metastatic Breast Cancer With Germline BRCA2 and “BRCAness” Mutations
- (2016) Sanghee Hong et al. Journal of Oncology Practice
- Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial
- (2015) D. Lorusso et al. ANNALS OF ONCOLOGY
- SWI/SNF Chromatin Remodeling and Human Malignancies
- (2015) Julien Masliah-Planchon et al. Annual Review of Pathology-Mechanisms of Disease
- Long-term safety and anti-tumour activity of olaparib monotherapy after combination with carboplatin and paclitaxel in patients with advanced breast, ovarian or fallopian tube cancer
- (2015) Ruud van der Noll et al. BRITISH JOURNAL OF CANCER
- Anti-programmed cell death protein-1/ligand-1 therapy in different cancers
- (2015) B Homet Moreno et al. BRITISH JOURNAL OF CANCER
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Genomic Classification of Cutaneous Melanoma
- (2015) Rehan Akbani et al. CELL
- BRCAness Predicts Resistance to Taxane-Containing Regimens in Triple Negative Breast Cancer During Neoadjuvant Chemotherapy
- (2015) Sadako Akashi-Tanaka et al. Clinical Breast Cancer
- ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer
- (2015) R. Govindan et al. CLINICAL CANCER RESEARCH
- Lung Master Protocol (Lung-MAP)--A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400
- (2015) R. S. Herbst et al. CLINICAL CANCER RESEARCH
- Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial
- (2015) L. A. Chantrill et al. CLINICAL CANCER RESEARCH
- Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA
- (2015) J. Uchida et al. CLINICAL CHEMISTRY
- What have we learned from exceptional tumour responses?
- (2015) Niven Mehra et al. CURRENT OPINION IN ONCOLOGY
- Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials
- (2015) David M. Hyman et al. DRUG DISCOVERY TODAY
- The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing
- (2015) Marcin Cieslik et al. GENOME RESEARCH
- Actionable exomic incidental findings in 6503 participants: challenges of variant classification
- (2015) Laura M. Amendola et al. GENOME RESEARCH
- Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth
- (2015) Rajen J. Mody et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
- (2015) Donavan T. Cheng et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- NCI-MATCH Launch Highlights New Trial Design in Precision-Medicine Era:
- (2015) Caroline McNeil JNCI-Journal of the National Cancer Institute
- Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories: Table 1.
- (2015) Victoria M. Raymond et al. JNCI-Journal of the National Cancer Institute
- A Decision Support Framework for Genomically Informed Investigational Cancer Therapy
- (2015) Funda Meric-Bernstam et al. JNCI-Journal of the National Cancer Institute
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
- (2015) Christophe Le Tourneau et al. LANCET ONCOLOGY
- Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non-V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team
- (2015) P. M. LoRusso et al. MOLECULAR CANCER THERAPEUTICS
- Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies
- (2015) Ellen Heitzer et al. Molecular Oncology
- Mutant MHC class II epitopes drive therapeutic immune responses to cancer
- (2015) Sebastian Kreiter et al. NATURE
- Alternative transcription initiation leads to expression of a novel ALK isoform in cancer
- (2015) Thomas Wiesner et al. NATURE
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- NCI-MATCH pairs tumor mutations with matching drugs
- (2015) Vicki Brower NATURE BIOTECHNOLOGY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Exceptional responders—discovering predictive biomarkers
- (2015) Naoko Takebe et al. Nature Reviews Clinical Oncology
- NCI-MATCH trial pushes cancer umbrella trial paradigm
- (2015) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Germline Mutations in Predisposition Genes in Pediatric Cancer
- (2015) Jinghui Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- ClinVar: public archive of interpretations of clinically relevant variants
- (2015) Melissa J. Landrum et al. NUCLEIC ACIDS RESEARCH
- Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors
- (2015) Joaquim Bellmunt et al. PLoS One
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- TERTpromoter mutations and telomerase reactivation in urothelial cancer
- (2015) Sumit Borah et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Precision cancer medicine: Hype or hope?
- (2015) Andrew Z. Wang Science Translational Medicine
- A mutational signature in gastric cancer suggests therapeutic strategies
- (2015) Ludmil B. Alexandrov et al. Nature Communications
- Patterns and functional implications of rare germline variants across 12 cancer types
- (2015) Charles Lu et al. Nature Communications
- Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations
- (2015) L. G. Ahronian et al. Cancer Discovery
- ARID1A and TERT promoter mutations in dedifferentiated meningioma
- (2015) Malak S. Abedalthagafi et al. Cancer Genetics
- A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells
- (2015) Elizabeth M. Matthew et al. Oncotarget
- Landscape of gene fusions in epithelial cancers: seq and ye shall find
- (2015) Chandan Kumar-Sinha et al. Genome Medicine
- NCI-MATCH Launch Highlights New Trial Design in Precision-Medicine Era:
- (2015) Caroline McNeil JNCI-Journal of the National Cancer Institute
- Germline Findings in Tumor-Only Sequencing: Points to Consider for Clinicians and Laboratories: Table 1.
- (2015) Victoria M. Raymond et al. JNCI-Journal of the National Cancer Institute
- A Decision Support Framework for Genomically Informed Investigational Cancer Therapy
- (2015) Funda Meric-Bernstam et al. JNCI-Journal of the National Cancer Institute
- Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma
- (2015) Eliezer M. Van Allen et al. JAMA Oncology
- Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response
- (2015) Himisha Beltran et al. JAMA Oncology
- Detection of Somatic Copy Number Alterations in Cancer Using Targeted Exome Capture Sequencing
- (2015) Robert J. Lonigro et al. NEOPLASIA
- Modeling tissue contamination to improve molecular identification of the primary tumor site of metastases
- (2014) Martin Vincent et al. BIOINFORMATICS
- A Proteome-Scale Map of the Human Interactome Network
- (2014) Thomas Rolland et al. CELL
- Mutational signatures: the patterns of somatic mutations hidden in cancer genomes
- (2014) Ludmil B Alexandrov et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Social and behavioral research in genomic sequencing: approaches from the Clinical Sequencing Exploratory Research Consortium Outcomes and Measures Working Group
- (2014) Stacy W. Gray et al. GENETICS IN MEDICINE
- Most common ‘sporadic’ cancers have a significant germline genetic component
- (2014) Yi Lu et al. HUMAN MOLECULAR GENETICS
- Non–Small Cell Lung Cancer and Precision Medicine
- (2014) Boris Pasche et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- (2014) Mark G. Kris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Significance of CTNNB1 Mutation and Wnt Pathway Activation in Endometrioid Endometrial Carcinoma
- (2014) Yuexin Liu et al. JNCI-Journal of the National Cancer Institute
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Integrated genomic characterization of adrenocortical carcinoma
- (2014) Guillaume Assié et al. NATURE GENETICS
- The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
- (2014) Gang Wu et al. NATURE GENETICS
- Genome-wide analysis of noncoding regulatory mutations in cancer
- (2014) Nils Weinhold et al. NATURE GENETICS
- Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types
- (2014) Nils J Fredriksson et al. NATURE GENETICS
- Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer
- (2014) Christine M Lovly et al. NATURE MEDICINE
- Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine
- (2014) Eliezer M Van Allen et al. NATURE MEDICINE
- Implementing personalized cancer care
- (2014) Richard L. Schilsky Nature Reviews Clinical Oncology
- Mechanisms underlying mutational signatures in human cancers
- (2014) Thomas Helleday et al. NATURE REVIEWS GENETICS
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders
- (2014) Joanna S. Amberger et al. NUCLEIC ACIDS RESEARCH
- Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma
- (2014) Jennifer A. Perry et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes
- (2014) Saravana M. Dhanasekaran et al. Nature Communications
- Synthetic Lethality in ATM-Deficient RAD50-Mutant Tumors Underlies Outlier Response to Cancer Therapy
- (2014) H. Al-Ahmadie et al. Cancer Discovery
- Activating mTOR Mutations in a Patient with an Extraordinary Response on a Phase I Trial of Everolimus and Pazopanib
- (2014) N. Wagle et al. Cancer Discovery
- APOBEC-Mediated Cytosine Deamination Links PIK3CA Helical Domain Mutations to Human Papillomavirus-Driven Tumor Development
- (2014) Stephen Henderson et al. Cell Reports
- RNA-Seq Accurately Identifies Cancer Biomarker Signatures to Distinguish Tissue of Origin
- (2014) Iris H. Wei et al. NEOPLASIA
- Personalized treatment of Sézary syndrome by targeting a novelCTLA4:CD28fusion
- (2014) Aleksandar Sekulic et al. Molecular Genetics & Genomic Medicine
- Promoting a new brain tumor mutation: TERT promoter mutations in CNS tumors
- (2013) Zachary J. Reitman et al. ACTA NEUROPATHOLOGICA
- ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
- (2013) Robert C. Green et al. GENETICS IN MEDICINE
- Integrative and Comparative Genomic Analysis of Lung Squamous Cell Carcinomas in East Asian Patients
- (2013) Youngwook Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative Effectiveness Research in Cancer Genomics and Precision Medicine: Current Landscape and Future Prospects
- (2013) N. I. Simonds et al. JNCI-Journal of the National Cancer Institute
- Landscape of DNA Virus Associations across Human Malignant Cancers: Analysis of 3,775 Cases Using RNA-Seq
- (2013) J. D. Khoury et al. JOURNAL OF VIROLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- (2013) Garrett M Frampton et al. NATURE BIOTECHNOLOGY
- APOBEC3B mutagenesis in cancer
- (2013) Kawai J Kuong et al. NATURE GENETICS
- Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation
- (2013) Guangwu Guo et al. NATURE GENETICS
- Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
- (2013) Dan R Robinson et al. NATURE GENETICS
- From neural development to cognition: unexpected roles for chromatin
- (2013) Jehnna L. Ronan et al. NATURE REVIEWS GENETICS
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
- (2013) P. W. Lewis et al. SCIENCE
- Frequency of TERT promoter mutations in human cancers
- (2013) João Vinagre et al. Nature Communications
- Identification of Targetable FGFR Gene Fusions in Diverse Cancers
- (2013) Yi-Mi Wu et al. Cancer Discovery
- K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
- (2012) Dong-Anh Khuong-Quang et al. ACTA NEUROPATHOLOGICA
- Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling
- (2012) K. A. Oien et al. ANNALS OF ONCOLOGY
- Exploiting the Mutanome for Tumor Vaccination
- (2012) J. C. Castle et al. CANCER RESEARCH
- Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
- (2012) Himisha Beltran et al. EUROPEAN UROLOGY
- Tumor Boards and the Quality of Cancer Care
- (2012) N. L. Keating et al. JNCI-Journal of the National Cancer Institute
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
- (2012) Jeremy Schwartzentruber et al. NATURE
- Assuring the quality of next-generation sequencing in clinical laboratory practice
- (2012) Amy S Gargis et al. NATURE BIOTECHNOLOGY
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genome Sequencing Identifies a Basis for Everolimus Sensitivity
- (2012) G. Iyer et al. SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- LOVD v.2.0: the next generation in gene variant databases
- (2011) Ivo F. A. C. Fokkema et al. HUMAN MUTATION
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
- (2011) Ignacio Varela et al. NATURE
- Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
- (2011) Yaoting Gui et al. NATURE GENETICS
- Carcinomas of an unknown primary origin—diagnosis and treatment
- (2011) Christophe Massard et al. Nature Reviews Clinical Oncology
- Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
- (2011) S. Roychowdhury et al. Science Translational Medicine
- High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing
- (2011) Nikhil Wagle et al. Cancer Discovery
- Translating cancer research into targeted therapeutics
- (2010) J. S. de Bono et al. NATURE
- A map of human genome variation from population-scale sequencing
- (2010) Richard M. Durbin et al. NATURE
- Genomic Analysis Using High-Density Single Nucleotide Polymorphism-Based Oligonucleotide Arrays and Multiplex Ligation-Dependent Probe Amplification Provides a Comprehensive Analysis of INI1/SMARCB1 in Malignant Rhabdoid Tumors
- (2009) E. M. Jackson et al. CLINICAL CANCER RESEARCH
- Evaluating the utility of personal genomic information
- (2009) Morris W Foster et al. GENETICS IN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search